These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 8046544)

  • 1. Failure of in vitro T-cell assays to predict clinical outcome after human kidney transplantation.
    Steinmann J; Kaden J; May G; Schröder K; Herwartz C; Müller-Ruchholtz W
    J Clin Lab Anal; 1994; 8(3):157-62. PubMed ID: 8046544
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pretransplant donor-specific helper T cell reactivity as a tool for tailoring the individual need for immunosuppression.
    van der Mast BJ; van Besouw NM; de Kuiper P; Vaessen LM; Gregoor PJ; IJzermans JN; van Gelder T; Claas FH; Weimar W
    Transplantation; 2001 Sep; 72(5):873-80. PubMed ID: 11571453
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of the donor-specific cytotoxic T lymphocyte repertoire in a patient with a long term surviving allograft. Frequency, specificity, and phenotype of donor-reactive T cell receptor (TCR)-alpha beta+ and TCR-gamma delta+ clones.
    Vandekerckhove BA; Datema G; Koning F; Goulmy E; Persijn GG; Van Rood JJ; Claas FH; De Vries JE
    J Immunol; 1990 Feb; 144(4):1288-94. PubMed ID: 2137487
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Donor-specific T-cell reactivity identifies kidney transplant patients in whom immunosuppressive therapy can be safely reduced.
    van Besouw NM; van der Mast BJ; de Kuiper P; Smak Gregoor PJ; Vaessen LM; IJzermans JN; van Gelder T; Weimar W
    Transplantation; 2000 Jul; 70(1):136-43. PubMed ID: 10919590
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microchimerism linked to cytotoxic T lymphocyte functional unresponsiveness (clonal anergy) in a tolerant renal transplant recipient.
    Burlingham WJ; Grailer AP; Fechner JH; Kusaka S; Trucco M; Kocova M; Belzer FO; Sollinger HW
    Transplantation; 1995 Apr; 59(8):1147-55. PubMed ID: 7732562
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of the immune status in the recipients with long-term well-functioning kidneys allografts.
    Nakagawa K; Matsuno T; Iwagaki H; Fujiwara T; Tanaka N
    Acta Med Okayama; 2001 Feb; 55(1):31-9. PubMed ID: 11246975
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective reduction of donor-specific cytotoxic T lymphocyte precursors in patients with a well-functioning kidney allograft.
    Herzog WR; Zanker B; Irschick E; Huber C; Franz HE; Wagner H; Kabelitz D
    Transplantation; 1987 Mar; 43(3):384-9. PubMed ID: 3547795
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kinetics of circulating cytotoxic T lymphocyte precursors that have a high avidity for donor antigens: correlation with the rejection status of the human cardiac allograft.
    van Emmerik NE; Vaessen LM; Knoop CJ; Daane CR; Balk AH; Mochtar B; Claas FH; Weimar W
    Transpl Immunol; 1998 Sep; 6(3):153-60. PubMed ID: 9848221
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo mechanisms of alloreactivity. II. Allospecificity of cytotoxic T lymphocytes in sponge matrix allografts as determined by limiting dilution analysis.
    Orosz CG; Zinn NE; Sirinek LP; Ferguson RM
    Transplantation; 1986 Jan; 41(1):84-92. PubMed ID: 2934879
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Longitudinal study of the frequency of cytotoxic T cell precursors in kidney allograft recipients.
    Mestre M; Massip E; Bas J; Alsina J; Romeu A; Castelao AM; Buendia E; Grinyo JM
    Clin Exp Immunol; 1996 Apr; 104(1):108-14. PubMed ID: 8603514
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Donor-specific cytotoxic T lymphocyte hyporesponsiveness following renal transplantation in patients pretreated with donor-specific transfusions.
    Grailer AP; Sollinger HW; Kawamura T; Burlingham WJ
    Transplantation; 1991 Feb; 51(2):320-4. PubMed ID: 1825241
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tolerance induction by "megadose" hematopoietic transplants: donor-type human CD34 stem cells induce potent specific reduction of host anti-donor cytotoxic T lymphocyte precursors in mixed lymphocyte culture.
    Rachamim N; Gan J; Segall H; Krauthgamer R; Marcus H; Berrebi A; Martelli M; Reisner Y
    Transplantation; 1998 May; 65(10):1386-93. PubMed ID: 9625023
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of post-transplant immune status in recipients of liver/bone marrow allografts.
    Chatzipetrou MA; Mathew JM; Kenyon NS; Esquenazi V; Miller J; Ricordi C; Tzakis AG
    Hum Immunol; 1999 Dec; 60(12):1281-8. PubMed ID: 10626743
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tracking donor-reactive T cells: Evidence for clonal deletion in tolerant kidney transplant patients.
    Morris H; DeWolf S; Robins H; Sprangers B; LoCascio SA; Shonts BA; Kawai T; Wong W; Yang S; Zuber J; Shen Y; Sykes M
    Sci Transl Med; 2015 Jan; 7(272):272ra10. PubMed ID: 25632034
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mobilization of T lymphocytes following cardiac transplantation. Evidence that CD4-positive cells are required for cytotoxic T lymphocyte activation, inflammatory endothelial development, graft infiltration, and acute allograft rejection.
    Bishop DK; Shelby J; Eichwald EJ
    Transplantation; 1992 Apr; 53(4):849-57. PubMed ID: 1533070
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyclosporine-induced tolerance in experimental organ transplantation. Evidence of diminished donor-specific cytotoxicity relative to donor-specific proliferative response.
    Norin AJ; Kamholz SL; Pinsker KL; Emeson EE; Veith FJ
    J Immunol; 1987 Jul; 139(2):332-7. PubMed ID: 2955037
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Minor histocompatibility antigen-specific cytotoxic T cell lines, capable of lysing human hematopoietic progenitor cells, can be generated in vitro by stimulation with HLA-identical bone marrow cells.
    Marijt WA; Veenhof WF; Brand A; Goulmy E; Fibbe WE; Willemze R; van Rood JJ; Falkenburg JH
    J Exp Med; 1991 Jan; 173(1):101-9. PubMed ID: 1985117
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of human in vivo cytotoxic T lymphocyte generation by cyclosporine following organ transplantation.
    Keown PA; Essery-Rice G; Hellstrom A; Sinclair NR; Stiller CR
    Transplantation; 1985 Jul; 40(1):45-9. PubMed ID: 3892796
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of IL-2 synthesis by donor-specific suppressor T cells in a renal transplant recipient.
    Okimoto T; Yahata H; Fukuda Y; Hayamizu K; Dohi K
    Transpl Int; 1994; 7 Suppl 1():S629-33. PubMed ID: 11271325
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relevance of pretransplant donor-specific T cell allorepertoire for human kidney graft survival.
    Bouma GJ; van der Meer-Prins EM; van der Woude FJ; van Rood JJ; Claas FH
    Transplantation; 1995 Apr; 59(7):969-76. PubMed ID: 7709457
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.